nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—SHBG—prostate cancer	0.0934	0.405	CbGaD
Spironolactone—AR—prostate cancer	0.0819	0.355	CbGaD
Spironolactone—Testosterone—Abiraterone—prostate cancer	0.0665	0.248	CrCrCtD
Spironolactone—NR3C1—prostate cancer	0.0556	0.241	CbGaD
Spironolactone—AR—Nilutamide—prostate cancer	0.0416	0.122	CbGbCtD
Spironolactone—AR—Bicalutamide—prostate cancer	0.0416	0.122	CbGbCtD
Spironolactone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.0374	0.14	CrCrCtD
Spironolactone—AR—Flutamide—prostate cancer	0.0345	0.101	CbGbCtD
Spironolactone—SHBG—Estrone—prostate cancer	0.0298	0.0876	CbGbCtD
Spironolactone—Testolactone—Estrone—prostate cancer	0.0282	0.105	CrCrCtD
Spironolactone—Testosterone—Estramustine—prostate cancer	0.0276	0.103	CrCrCtD
Spironolactone—SHBG—Ethinyl Estradiol—prostate cancer	0.0266	0.0781	CbGbCtD
Spironolactone—Testosterone—Estrone—prostate cancer	0.022	0.0818	CrCrCtD
Spironolactone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0182	0.068	CrCrCtD
Spironolactone—SHBG—Estradiol—prostate cancer	0.0171	0.0503	CbGbCtD
Spironolactone—Testosterone—Estradiol—prostate cancer	0.0166	0.062	CrCrCtD
Spironolactone—AR—Estradiol—prostate cancer	0.0143	0.0421	CbGbCtD
Spironolactone—SLCO1A2—Estrone—prostate cancer	0.0137	0.0402	CbGbCtD
Spironolactone—Potassium Canrenoate—Prednisone—prostate cancer	0.0106	0.0396	CrCrCtD
Spironolactone—ABCC2—Ethinyl Estradiol—prostate cancer	0.0101	0.0297	CbGbCtD
Spironolactone—CYP2C8—Nilutamide—prostate cancer	0.00911	0.0268	CbGbCtD
Spironolactone—SLCO1A2—Conjugated Estrogens—prostate cancer	0.00894	0.0263	CbGbCtD
Spironolactone—SLCO1A2—Estradiol—prostate cancer	0.00785	0.0231	CbGbCtD
Spironolactone—NR3C1—Prednisone—prostate cancer	0.00783	0.023	CbGbCtD
Spironolactone—Hydrocortamate—Prednisone—prostate cancer	0.0078	0.0291	CrCrCtD
Spironolactone—Cortisone acetate—Prednisone—prostate cancer	0.00756	0.0282	CrCrCtD
Spironolactone—CYP2C8—Abiraterone—prostate cancer	0.00755	0.0222	CbGbCtD
Spironolactone—ABCC2—Conjugated Estrogens—prostate cancer	0.00741	0.0218	CbGbCtD
Spironolactone—Testolactone—Prednisone—prostate cancer	0.00734	0.0273	CrCrCtD
Spironolactone—SLCO1A2—Prednisone—prostate cancer	0.00675	0.0198	CbGbCtD
Spironolactone—Fludrocortisone—Prednisone—prostate cancer	0.00657	0.0245	CrCrCtD
Spironolactone—Methyltestosterone—Prednisone—prostate cancer	0.00641	0.0239	CrCrCtD
Spironolactone—ABCB1—Estramustine—prostate cancer	0.00573	0.0169	CbGbCtD
Spironolactone—CYP2C8—Cabazitaxel—prostate cancer	0.00558	0.0164	CbGbCtD
Spironolactone—Hydrocortisone—Prednisone—prostate cancer	0.00536	0.02	CrCrCtD
Spironolactone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00486	0.0143	CbGbCtD
Spironolactone—ABCC2—Etoposide—prostate cancer	0.00425	0.0125	CbGbCtD
Spironolactone—ABCC2—Docetaxel—prostate cancer	0.00389	0.0114	CbGbCtD
Spironolactone—ABCB1—Cabazitaxel—prostate cancer	0.00378	0.0111	CbGbCtD
Spironolactone—ABCB1—Estrone—prostate cancer	0.00369	0.0109	CbGbCtD
Spironolactone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00329	0.00968	CbGbCtD
Spironolactone—CYP2C8—Estradiol—prostate cancer	0.00313	0.00922	CbGbCtD
Spironolactone—SHBG—semen—prostate cancer	0.00294	0.123	CbGeAlD
Spironolactone—ABCC2—Doxorubicin—prostate cancer	0.0029	0.00852	CbGbCtD
Spironolactone—ABCB1—Conjugated Estrogens—prostate cancer	0.00242	0.00711	CbGbCtD
Spironolactone—AR—penis—prostate cancer	0.00221	0.0923	CbGeAlD
Spironolactone—ABCB1—Mitoxantrone—prostate cancer	0.0022	0.00646	CbGbCtD
Spironolactone—ABCB1—Estradiol—prostate cancer	0.00212	0.00624	CbGbCtD
Spironolactone—AR—semen—prostate cancer	0.00211	0.088	CbGeAlD
Spironolactone—CYP2C8—Etoposide—prostate cancer	0.00205	0.00602	CbGbCtD
Spironolactone—ABCB1—Prednisone—prostate cancer	0.00182	0.00536	CbGbCtD
Spironolactone—ABCB1—Etoposide—prostate cancer	0.00138	0.00407	CbGbCtD
Spironolactone—ABCB1—Docetaxel—prostate cancer	0.00127	0.00373	CbGbCtD
Spironolactone—CYP11B2—renal system—prostate cancer	0.0011	0.046	CbGeAlD
Spironolactone—NR3C1—urine—prostate cancer	0.00107	0.0445	CbGeAlD
Spironolactone—ABCB1—Doxorubicin—prostate cancer	0.000945	0.00278	CbGbCtD
Spironolactone—SHBG—prostate gland—prostate cancer	0.000736	0.0307	CbGeAlD
Spironolactone—NR3C2—prostate gland—prostate cancer	0.000714	0.0298	CbGeAlD
Spironolactone—PGR—prostate gland—prostate cancer	0.000663	0.0277	CbGeAlD
Spironolactone—NR3C2—seminal vesicle—prostate cancer	0.000604	0.0252	CbGeAlD
Spironolactone—ABCC2—prostate gland—prostate cancer	0.00057	0.0238	CbGeAlD
Spironolactone—AR—prostate gland—prostate cancer	0.000529	0.0221	CbGeAlD
Spironolactone—CYP11B2—lymph node—prostate cancer	0.000516	0.0215	CbGeAlD
Spironolactone—PGR—epithelium—prostate cancer	0.000487	0.0203	CbGeAlD
Spironolactone—NR3C2—renal system—prostate cancer	0.000486	0.0203	CbGeAlD
Spironolactone—NR3C2—urethra—prostate cancer	0.000478	0.0199	CbGeAlD
Spironolactone—AR—seminal vesicle—prostate cancer	0.000447	0.0187	CbGeAlD
Spironolactone—SLCO1A2—renal system—prostate cancer	0.000417	0.0174	CbGeAlD
Spironolactone—ABCC2—renal system—prostate cancer	0.000388	0.0162	CbGeAlD
Spironolactone—AR—epithelium—prostate cancer	0.000388	0.0162	CbGeAlD
Spironolactone—NR3C1—prostate gland—prostate cancer	0.000383	0.016	CbGeAlD
Spironolactone—SHBG—bone marrow—prostate cancer	0.00038	0.0158	CbGeAlD
Spironolactone—AR—renal system—prostate cancer	0.00036	0.015	CbGeAlD
Spironolactone—AR—urethra—prostate cancer	0.000354	0.0148	CbGeAlD
Spironolactone—SHBG—testis—prostate cancer	0.000324	0.0135	CbGeAlD
Spironolactone—NR3C1—seminal vesicle—prostate cancer	0.000324	0.0135	CbGeAlD
Spironolactone—NR3C2—testis—prostate cancer	0.000314	0.0131	CbGeAlD
Spironolactone—PGR—testis—prostate cancer	0.000292	0.0122	CbGeAlD
Spironolactone—CYP2C8—renal system—prostate cancer	0.000291	0.0122	CbGeAlD
Spironolactone—NR3C1—epithelium—prostate cancer	0.000281	0.0117	CbGeAlD
Spironolactone—SLCO1A2—testis—prostate cancer	0.000269	0.0112	CbGeAlD
Spironolactone—NR3C1—renal system—prostate cancer	0.000261	0.0109	CbGeAlD
Spironolactone—NR3C1—urethra—prostate cancer	0.000256	0.0107	CbGeAlD
Spironolactone—ABCC2—testis—prostate cancer	0.000251	0.0105	CbGeAlD
Spironolactone—AR—testis—prostate cancer	0.000233	0.00972	CbGeAlD
Spironolactone—NR3C2—lymph node—prostate cancer	0.000228	0.00951	CbGeAlD
Spironolactone—PGR—lymph node—prostate cancer	0.000212	0.00884	CbGeAlD
Spironolactone—ABCB1—prostate gland—prostate cancer	0.000205	0.00855	CbGeAlD
Spironolactone—NR3C1—bone marrow—prostate cancer	0.000197	0.00823	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.00019	0.0688	CrCbGaD
Spironolactone—CYP2C8—testis—prostate cancer	0.000188	0.00786	CbGeAlD
Spironolactone—ABCC2—lymph node—prostate cancer	0.000182	0.00759	CbGeAlD
Spironolactone—ABCB1—seminal vesicle—prostate cancer	0.000173	0.00723	CbGeAlD
Spironolactone—AR—lymph node—prostate cancer	0.000169	0.00704	CbGeAlD
Spironolactone—NR3C1—testis—prostate cancer	0.000169	0.00704	CbGeAlD
Spironolactone—ABCB1—epithelium—prostate cancer	0.000151	0.00628	CbGeAlD
Spironolactone—Oxandrolone—AR—prostate cancer	0.000149	0.0538	CrCbGaD
Spironolactone—ABCB1—renal system—prostate cancer	0.00014	0.00583	CbGeAlD
Spironolactone—ABCB1—urethra—prostate cancer	0.000137	0.00573	CbGeAlD
Spironolactone—NR3C1—lymph node—prostate cancer	0.000122	0.0051	CbGeAlD
Spironolactone—ABCB1—bone marrow—prostate cancer	0.000106	0.00441	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	0.000105	0.0381	CrCbGaD
Spironolactone—Testosterone Propionate—CYP17A1—prostate cancer	9.94e-05	0.0359	CrCbGaD
Spironolactone—Hydrocortisone—ANXA1—prostate cancer	9.76e-05	0.0353	CrCbGaD
Spironolactone—Testosterone—CYP3A43—prostate cancer	9.51e-05	0.0344	CrCbGaD
Spironolactone—Testolactone—CYP19A1—prostate cancer	9.31e-05	0.0336	CrCbGaD
Spironolactone—ABCB1—testis—prostate cancer	9.03e-05	0.00377	CbGeAlD
Spironolactone—Hyperkalaemia—Epirubicin—prostate cancer	9.02e-05	0.00139	CcSEcCtD
Spironolactone—Renal failure—Etoposide—prostate cancer	9.01e-05	0.00138	CcSEcCtD
Spironolactone—Ataxia—Capecitabine—prostate cancer	9e-05	0.00138	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—prostate cancer	8.98e-05	0.00138	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Docetaxel—prostate cancer	8.9e-05	0.00137	CcSEcCtD
Spironolactone—Cramp muscle—Docetaxel—prostate cancer	8.9e-05	0.00137	CcSEcCtD
Spironolactone—Muscle spasms—Estradiol—prostate cancer	8.89e-05	0.00137	CcSEcCtD
Spironolactone—Alopecia—Mitoxantrone—prostate cancer	8.74e-05	0.00134	CcSEcCtD
Spironolactone—Lethargy—Prednisone—prostate cancer	8.7e-05	0.00134	CcSEcCtD
Spironolactone—Vomiting—Bicalutamide—prostate cancer	8.7e-05	0.00134	CcSEcCtD
Spironolactone—Rash—Bicalutamide—prostate cancer	8.62e-05	0.00133	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Capecitabine—prostate cancer	8.62e-05	0.00132	CcSEcCtD
Spironolactone—Dermatitis—Bicalutamide—prostate cancer	8.62e-05	0.00132	CcSEcCtD
Spironolactone—Ill-defined disorder—Estradiol—prostate cancer	8.57e-05	0.00132	CcSEcCtD
Spironolactone—Headache—Bicalutamide—prostate cancer	8.57e-05	0.00132	CcSEcCtD
Spironolactone—Agranulocytosis—Etoposide—prostate cancer	8.55e-05	0.00131	CcSEcCtD
Spironolactone—Hypersensitivity—Ethinyl Estradiol—prostate cancer	8.52e-05	0.00131	CcSEcCtD
Spironolactone—Gastritis—Capecitabine—prostate cancer	8.47e-05	0.0013	CcSEcCtD
Spironolactone—Somnolence—Goserelin—prostate cancer	8.46e-05	0.0013	CcSEcCtD
Spironolactone—Cramps of lower extremities—Epirubicin—prostate cancer	8.44e-05	0.0013	CcSEcCtD
Spironolactone—Somnolence—Conjugated Estrogens—prostate cancer	8.38e-05	0.00129	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—prostate cancer	8.35e-05	0.00128	CcSEcCtD
Spironolactone—Malaise—Estradiol—prostate cancer	8.33e-05	0.00128	CcSEcCtD
Spironolactone—Pruritus—Ethinyl Estradiol—prostate cancer	8.18e-05	0.00126	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	8.14e-05	0.00125	CcSEcCtD
Spironolactone—Nausea—Bicalutamide—prostate cancer	8.12e-05	0.00125	CcSEcCtD
Spironolactone—Testosterone Propionate—COMT—prostate cancer	8.1e-05	0.0293	CrCbGaD
Spironolactone—Ill-defined disorder—Mitoxantrone—prostate cancer	7.99e-05	0.00123	CcSEcCtD
Spironolactone—Diarrhoea—Ethinyl Estradiol—prostate cancer	7.91e-05	0.00122	CcSEcCtD
Spironolactone—Feeling abnormal—Goserelin—prostate cancer	7.84e-05	0.00121	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—prostate cancer	7.81e-05	0.0012	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—prostate cancer	7.78e-05	0.0012	CcSEcCtD
Spironolactone—Discomfort—Estradiol—prostate cancer	7.77e-05	0.00119	CcSEcCtD
Spironolactone—Malaise—Mitoxantrone—prostate cancer	7.77e-05	0.00119	CcSEcCtD
Spironolactone—Leukopenia—Mitoxantrone—prostate cancer	7.71e-05	0.00118	CcSEcCtD
Spironolactone—Dizziness—Ethinyl Estradiol—prostate cancer	7.64e-05	0.00118	CcSEcCtD
Spironolactone—Confusional state—Estradiol—prostate cancer	7.61e-05	0.00117	CcSEcCtD
Spironolactone—Urticaria—Goserelin—prostate cancer	7.56e-05	0.00116	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—prostate cancer	7.55e-05	0.00116	CcSEcCtD
Spironolactone—Anaphylactic shock—Estradiol—prostate cancer	7.54e-05	0.00116	CcSEcCtD
Spironolactone—Body temperature increased—Goserelin—prostate cancer	7.52e-05	0.00116	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—prostate cancer	7.49e-05	0.00115	CcSEcCtD
Spironolactone—Urticaria—Conjugated Estrogens—prostate cancer	7.49e-05	0.00115	CcSEcCtD
Spironolactone—Body temperature increased—Conjugated Estrogens—prostate cancer	7.45e-05	0.00115	CcSEcCtD
Spironolactone—Vomiting—Ethinyl Estradiol—prostate cancer	7.35e-05	0.00113	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Capecitabine—prostate cancer	7.31e-05	0.00112	CcSEcCtD
Spironolactone—Rash—Ethinyl Estradiol—prostate cancer	7.29e-05	0.00112	CcSEcCtD
Spironolactone—Dermatitis—Ethinyl Estradiol—prostate cancer	7.28e-05	0.00112	CcSEcCtD
Spironolactone—Alopecia—Etoposide—prostate cancer	7.27e-05	0.00112	CcSEcCtD
Spironolactone—Renal failure—Capecitabine—prostate cancer	7.25e-05	0.00111	CcSEcCtD
Spironolactone—Discomfort—Mitoxantrone—prostate cancer	7.24e-05	0.00111	CcSEcCtD
Spironolactone—Headache—Ethinyl Estradiol—prostate cancer	7.24e-05	0.00111	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—prostate cancer	7.22e-05	0.00111	CcSEcCtD
Spironolactone—Drospirenone—AR—prostate cancer	7.2e-05	0.026	CrCbGaD
Spironolactone—Agranulocytosis—Docetaxel—prostate cancer	7.11e-05	0.00109	CcSEcCtD
Spironolactone—Confusional state—Mitoxantrone—prostate cancer	7.09e-05	0.00109	CcSEcCtD
Spironolactone—Anaphylactic shock—Mitoxantrone—prostate cancer	7.03e-05	0.00108	CcSEcCtD
Spironolactone—Hypersensitivity—Goserelin—prostate cancer	7.01e-05	0.00108	CcSEcCtD
Spironolactone—Hypersensitivity—Conjugated Estrogens—prostate cancer	6.94e-05	0.00107	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—prostate cancer	6.89e-05	0.00106	CcSEcCtD
Spironolactone—Agranulocytosis—Capecitabine—prostate cancer	6.88e-05	0.00106	CcSEcCtD
Spironolactone—Thrombocytopenia—Mitoxantrone—prostate cancer	6.88e-05	0.00106	CcSEcCtD
Spironolactone—Nausea—Ethinyl Estradiol—prostate cancer	6.87e-05	0.00106	CcSEcCtD
Spironolactone—Eplerenone—CYP3A5—prostate cancer	6.82e-05	0.0247	CrCbGaD
Spironolactone—Lethargy—Epirubicin—prostate cancer	6.8e-05	0.00105	CcSEcCtD
Spironolactone—Erectile dysfunction—Prednisone—prostate cancer	6.79e-05	0.00104	CcSEcCtD
Spironolactone—Fludrocortisone—AR—prostate cancer	6.78e-05	0.0245	CrCbGaD
Spironolactone—Pruritus—Goserelin—prostate cancer	6.73e-05	0.00103	CcSEcCtD
Spironolactone—Somnolence—Estradiol—prostate cancer	6.71e-05	0.00103	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—prostate cancer	6.68e-05	0.00103	CcSEcCtD
Spironolactone—Pruritus—Conjugated Estrogens—prostate cancer	6.67e-05	0.00102	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—prostate cancer	6.65e-05	0.00102	CcSEcCtD
Spironolactone—ABCB1—lymph node—prostate cancer	6.54e-05	0.00273	CbGeAlD
Spironolactone—Gastrointestinal disorder—Estradiol—prostate cancer	6.51e-05	0.001	CcSEcCtD
Spironolactone—Diarrhoea—Goserelin—prostate cancer	6.51e-05	0.001	CcSEcCtD
Spironolactone—Erythema multiforme—Docetaxel—prostate cancer	6.47e-05	0.000994	CcSEcCtD
Spironolactone—Malaise—Etoposide—prostate cancer	6.46e-05	0.000993	CcSEcCtD
Spironolactone—Diarrhoea—Conjugated Estrogens—prostate cancer	6.45e-05	0.000991	CcSEcCtD
Spironolactone—Leukopenia—Etoposide—prostate cancer	6.41e-05	0.000985	CcSEcCtD
Spironolactone—Fluoxymesterone—SHBG—prostate cancer	6.39e-05	0.0231	CrCbGaD
Spironolactone—Lethargy—Doxorubicin—prostate cancer	6.3e-05	0.000968	CcSEcCtD
Spironolactone—Dizziness—Goserelin—prostate cancer	6.29e-05	0.000967	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—prostate cancer	6.27e-05	0.000964	CcSEcCtD
Spironolactone—Erythema multiforme—Capecitabine—prostate cancer	6.26e-05	0.000962	CcSEcCtD
Spironolactone—Somnolence—Mitoxantrone—prostate cancer	6.25e-05	0.00096	CcSEcCtD
Spironolactone—Dizziness—Conjugated Estrogens—prostate cancer	6.23e-05	0.000958	CcSEcCtD
Spironolactone—Feeling abnormal—Estradiol—prostate cancer	6.22e-05	0.000955	CcSEcCtD
Spironolactone—Vomiting—Goserelin—prostate cancer	6.05e-05	0.00093	CcSEcCtD
Spironolactone—Testosterone Propionate—AR—prostate cancer	6.04e-05	0.0218	CrCbGaD
Spironolactone—Alopecia—Docetaxel—prostate cancer	6.04e-05	0.000929	CcSEcCtD
Spironolactone—Discomfort—Etoposide—prostate cancer	6.03e-05	0.000926	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—prostate cancer	6e-05	0.000923	CcSEcCtD
Spironolactone—Rash—Goserelin—prostate cancer	6e-05	0.000922	CcSEcCtD
Spironolactone—Dermatitis—Goserelin—prostate cancer	5.99e-05	0.000921	CcSEcCtD
Spironolactone—Vomiting—Conjugated Estrogens—prostate cancer	5.99e-05	0.000921	CcSEcCtD
Spironolactone—Urticaria—Estradiol—prostate cancer	5.99e-05	0.000921	CcSEcCtD
Spironolactone—Body temperature increased—Estradiol—prostate cancer	5.96e-05	0.000916	CcSEcCtD
Spironolactone—Headache—Goserelin—prostate cancer	5.96e-05	0.000916	CcSEcCtD
Spironolactone—Rash—Conjugated Estrogens—prostate cancer	5.94e-05	0.000913	CcSEcCtD
Spironolactone—Dermatitis—Conjugated Estrogens—prostate cancer	5.94e-05	0.000912	CcSEcCtD
Spironolactone—Headache—Conjugated Estrogens—prostate cancer	5.9e-05	0.000907	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—prostate cancer	5.9e-05	0.000907	CcSEcCtD
Spironolactone—Confusional state—Etoposide—prostate cancer	5.89e-05	0.000906	CcSEcCtD
Spironolactone—Hydrocortamate—NR3C1—prostate cancer	5.89e-05	0.0213	CrCbGaD
Spironolactone—Alopecia—Capecitabine—prostate cancer	5.85e-05	0.000899	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—prostate cancer	5.85e-05	0.000898	CcSEcCtD
Spironolactone—Cortisone acetate—NR3C1—prostate cancer	5.8e-05	0.021	CrCbGaD
Spironolactone—Ataxia—Doxorubicin—prostate cancer	5.8e-05	0.000892	CcSEcCtD
Spironolactone—Feeling abnormal—Mitoxantrone—prostate cancer	5.79e-05	0.00089	CcSEcCtD
Spironolactone—Thrombocytopenia—Etoposide—prostate cancer	5.72e-05	0.00088	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—prostate cancer	5.72e-05	0.00088	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—prostate cancer	5.71e-05	0.000877	CcSEcCtD
Spironolactone—Nausea—Goserelin—prostate cancer	5.65e-05	0.000869	CcSEcCtD
Spironolactone—Fluoxymesterone—AR—prostate cancer	5.6e-05	0.0202	CrCbGaD
Spironolactone—Nausea—Conjugated Estrogens—prostate cancer	5.6e-05	0.00086	CcSEcCtD
Spironolactone—Megestrol acetate—NR3C1—prostate cancer	5.59e-05	0.0202	CrCbGaD
Spironolactone—Urticaria—Mitoxantrone—prostate cancer	5.58e-05	0.000858	CcSEcCtD
Spironolactone—Hypersensitivity—Estradiol—prostate cancer	5.56e-05	0.000854	CcSEcCtD
Spironolactone—Body temperature increased—Mitoxantrone—prostate cancer	5.56e-05	0.000854	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	5.56e-05	0.000854	CcSEcCtD
Spironolactone—Muscle spasms—Capecitabine—prostate cancer	5.54e-05	0.000852	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—SHBG—prostate cancer	5.48e-05	0.0198	CrCbGaD
Spironolactone—Gastritis—Doxorubicin—prostate cancer	5.46e-05	0.000839	CcSEcCtD
Spironolactone—Ill-defined disorder—Capecitabine—prostate cancer	5.35e-05	0.000822	CcSEcCtD
Spironolactone—Pruritus—Estradiol—prostate cancer	5.34e-05	0.00082	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—prostate cancer	5.33e-05	0.000819	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—prostate cancer	5.28e-05	0.000811	CcSEcCtD
Spironolactone—Alopecia—Prednisone—prostate cancer	5.21e-05	0.000801	CcSEcCtD
Spironolactone—Malaise—Capecitabine—prostate cancer	5.2e-05	0.000799	CcSEcCtD
Spironolactone—Somnolence—Etoposide—prostate cancer	5.2e-05	0.000799	CcSEcCtD
Spironolactone—Hypersensitivity—Mitoxantrone—prostate cancer	5.18e-05	0.000796	CcSEcCtD
Spironolactone—Diarrhoea—Estradiol—prostate cancer	5.16e-05	0.000793	CcSEcCtD
Spironolactone—Leukopenia—Capecitabine—prostate cancer	5.16e-05	0.000793	CcSEcCtD
Spironolactone—Methyltestosterone—SHBG—prostate cancer	5.16e-05	0.0186	CrCbGaD
Spironolactone—Drowsiness—Epirubicin—prostate cancer	5.14e-05	0.00079	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—prostate cancer	5.09e-05	0.000783	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—prostate cancer	5.05e-05	0.000776	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—prostate cancer	5.05e-05	0.000776	CcSEcCtD
Spironolactone—Dizziness—Estradiol—prostate cancer	4.99e-05	0.000767	CcSEcCtD
Spironolactone—Confusional state—Docetaxel—prostate cancer	4.9e-05	0.000753	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—prostate cancer	4.86e-05	0.000747	CcSEcCtD
Spironolactone—Discomfort—Capecitabine—prostate cancer	4.85e-05	0.000745	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—prostate cancer	4.82e-05	0.00074	CcSEcCtD
Spironolactone—Diarrhoea—Mitoxantrone—prostate cancer	4.81e-05	0.000739	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—AR—prostate cancer	4.8e-05	0.0174	CrCbGaD
Spironolactone—Vomiting—Estradiol—prostate cancer	4.8e-05	0.000737	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—prostate cancer	4.79e-05	0.000737	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisone—prostate cancer	4.76e-05	0.000732	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—prostate cancer	4.76e-05	0.000731	CcSEcCtD
Spironolactone—Rash—Estradiol—prostate cancer	4.76e-05	0.000731	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—prostate cancer	4.75e-05	0.000731	CcSEcCtD
Spironolactone—Dermatitis—Estradiol—prostate cancer	4.75e-05	0.00073	CcSEcCtD
Spironolactone—Confusional state—Capecitabine—prostate cancer	4.74e-05	0.000729	CcSEcCtD
Spironolactone—Headache—Estradiol—prostate cancer	4.73e-05	0.000726	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	4.71e-05	0.000724	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—prostate cancer	4.67e-05	0.000718	CcSEcCtD
Spironolactone—Urticaria—Etoposide—prostate cancer	4.64e-05	0.000714	CcSEcCtD
Spironolactone—Malaise—Prednisone—prostate cancer	4.63e-05	0.000712	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—prostate cancer	4.62e-05	0.00071	CcSEcCtD
Spironolactone—Thrombocytopenia—Capecitabine—prostate cancer	4.61e-05	0.000708	CcSEcCtD
Spironolactone—Fludrocortisone—NR3C1—prostate cancer	4.6e-05	0.0166	CrCbGaD
Spironolactone—Progesterone—CYP17A1—prostate cancer	4.57e-05	0.0165	CrCbGaD
Spironolactone—Methyltestosterone—AR—prostate cancer	4.52e-05	0.0163	CrCbGaD
Spironolactone—Nausea—Estradiol—prostate cancer	4.48e-05	0.000689	CcSEcCtD
Spironolactone—Vomiting—Mitoxantrone—prostate cancer	4.47e-05	0.000687	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—prostate cancer	4.44e-05	0.000682	CcSEcCtD
Spironolactone—Rash—Mitoxantrone—prostate cancer	4.43e-05	0.000681	CcSEcCtD
Spironolactone—Dermatitis—Mitoxantrone—prostate cancer	4.43e-05	0.00068	CcSEcCtD
Spironolactone—Headache—Mitoxantrone—prostate cancer	4.4e-05	0.000677	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—prostate cancer	4.36e-05	0.00067	CcSEcCtD
Spironolactone—Progesterone—SLC22A3—prostate cancer	4.35e-05	0.0157	CrCbGaD
Spironolactone—Somnolence—Docetaxel—prostate cancer	4.32e-05	0.000664	CcSEcCtD
Spironolactone—Discomfort—Prednisone—prostate cancer	4.32e-05	0.000664	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—prostate cancer	4.31e-05	0.0156	CrCbGaD
Spironolactone—Hypersensitivity—Etoposide—prostate cancer	4.31e-05	0.000662	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Docetaxel—prostate cancer	4.19e-05	0.000645	CcSEcCtD
Spironolactone—Anaphylactic shock—Prednisone—prostate cancer	4.19e-05	0.000644	CcSEcCtD
Spironolactone—Nausea—Mitoxantrone—prostate cancer	4.17e-05	0.000642	CcSEcCtD
Spironolactone—Pruritus—Etoposide—prostate cancer	4.14e-05	0.000636	CcSEcCtD
Spironolactone—Testosterone—SLC22A3—prostate cancer	4.12e-05	0.0149	CrCbGaD
Spironolactone—Alopecia—Epirubicin—prostate cancer	4.08e-05	0.000626	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Capecitabine—prostate cancer	4.06e-05	0.000624	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—prostate cancer	4.04e-05	0.00062	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—prostate cancer	4e-05	0.000615	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—prostate cancer	4e-05	0.000615	CcSEcCtD
Spironolactone—Hydrocortisone—SHBG—prostate cancer	3.88e-05	0.014	CrCbGaD
Spironolactone—Feeling abnormal—Capecitabine—prostate cancer	3.88e-05	0.000596	CcSEcCtD
Spironolactone—Dizziness—Etoposide—prostate cancer	3.87e-05	0.000594	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—prostate cancer	3.86e-05	0.000593	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—prostate cancer	3.84e-05	0.00059	CcSEcCtD
Spironolactone—Fluoxymesterone—NR3C1—prostate cancer	3.8e-05	0.0137	CrCbGaD
Spironolactone—Methyltestosterone—CYP19A1—prostate cancer	3.79e-05	0.0137	CrCbGaD
Spironolactone—Alopecia—Doxorubicin—prostate cancer	3.77e-05	0.00058	CcSEcCtD
Spironolactone—Urticaria—Capecitabine—prostate cancer	3.74e-05	0.000574	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—prostate cancer	3.73e-05	0.000573	CcSEcCtD
Spironolactone—Body temperature increased—Capecitabine—prostate cancer	3.72e-05	0.000572	CcSEcCtD
Spironolactone—Vomiting—Etoposide—prostate cancer	3.72e-05	0.000571	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—prostate cancer	3.7e-05	0.0134	CrCbGaD
Spironolactone—Rash—Etoposide—prostate cancer	3.69e-05	0.000567	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—prostate cancer	3.68e-05	0.000566	CcSEcCtD
Spironolactone—Headache—Etoposide—prostate cancer	3.66e-05	0.000563	CcSEcCtD
Spironolactone—Malaise—Epirubicin—prostate cancer	3.62e-05	0.000557	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—prostate cancer	3.59e-05	0.000552	CcSEcCtD
Spironolactone—Hypersensitivity—Docetaxel—prostate cancer	3.58e-05	0.00055	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—prostate cancer	3.57e-05	0.000549	CcSEcCtD
Spironolactone—Nausea—Etoposide—prostate cancer	3.47e-05	0.000534	CcSEcCtD
Spironolactone—Hypersensitivity—Capecitabine—prostate cancer	3.47e-05	0.000533	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisone—prostate cancer	3.45e-05	0.000531	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—prostate cancer	3.45e-05	0.00053	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—prostate cancer	3.44e-05	0.000528	CcSEcCtD
Spironolactone—Hydrocortamate—CYP3A4—prostate cancer	3.42e-05	0.0123	CrCbGaD
Spironolactone—Discomfort—Epirubicin—prostate cancer	3.38e-05	0.000519	CcSEcCtD
Spironolactone—Cortisone acetate—CYP3A4—prostate cancer	3.36e-05	0.0122	CrCbGaD
Spironolactone—Malaise—Doxorubicin—prostate cancer	3.35e-05	0.000515	CcSEcCtD
Spironolactone—Urticaria—Prednisone—prostate cancer	3.33e-05	0.000512	CcSEcCtD
Spironolactone—Pruritus—Capecitabine—prostate cancer	3.33e-05	0.000511	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—prostate cancer	3.33e-05	0.000511	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—prostate cancer	3.32e-05	0.000511	CcSEcCtD
Spironolactone—Body temperature increased—Prednisone—prostate cancer	3.31e-05	0.000509	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—prostate cancer	3.3e-05	0.000508	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—prostate cancer	3.28e-05	0.000504	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	3.26e-05	0.0118	CrCbGaD
Spironolactone—Diarrhoea—Capecitabine—prostate cancer	3.22e-05	0.000495	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—prostate cancer	3.21e-05	0.000494	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—prostate cancer	3.21e-05	0.000493	CcSEcCtD
Spironolactone—Progesterone—SHBG—prostate cancer	3.16e-05	0.0114	CrCbGaD
Spironolactone—Progesterone—CYP1B1—prostate cancer	3.16e-05	0.0114	CrCbGaD
Spironolactone—Discomfort—Doxorubicin—prostate cancer	3.12e-05	0.00048	CcSEcCtD
Spironolactone—Progesterone—SLC22A1—prostate cancer	3.12e-05	0.0113	CrCbGaD
Spironolactone—Dizziness—Capecitabine—prostate cancer	3.11e-05	0.000478	CcSEcCtD
Spironolactone—Hydrocortisone—CYP3A5—prostate cancer	3.09e-05	0.0112	CrCbGaD
Spironolactone—Vomiting—Docetaxel—prostate cancer	3.09e-05	0.000475	CcSEcCtD
Spironolactone—Hypersensitivity—Prednisone—prostate cancer	3.09e-05	0.000474	CcSEcCtD
Spironolactone—Rash—Docetaxel—prostate cancer	3.06e-05	0.000471	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—prostate cancer	3.06e-05	0.00047	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—prostate cancer	3.06e-05	0.00047	CcSEcCtD
Spironolactone—Headache—Docetaxel—prostate cancer	3.04e-05	0.000468	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—prostate cancer	3.03e-05	0.000466	CcSEcCtD
Spironolactone—Testosterone—SHBG—prostate cancer	2.99e-05	0.0108	CrCbGaD
Spironolactone—Testosterone—CYP1B1—prostate cancer	2.99e-05	0.0108	CrCbGaD
Spironolactone—Vomiting—Capecitabine—prostate cancer	2.99e-05	0.00046	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—prostate cancer	2.97e-05	0.000456	CcSEcCtD
Spironolactone—Rash—Capecitabine—prostate cancer	2.97e-05	0.000456	CcSEcCtD
Spironolactone—Pruritus—Prednisone—prostate cancer	2.96e-05	0.000456	CcSEcCtD
Spironolactone—Dermatitis—Capecitabine—prostate cancer	2.96e-05	0.000455	CcSEcCtD
Spironolactone—Eplerenone—CYP3A4—prostate cancer	2.95e-05	0.0107	CrCbGaD
Spironolactone—Testosterone—SLC22A1—prostate cancer	2.95e-05	0.0107	CrCbGaD
Spironolactone—Headache—Capecitabine—prostate cancer	2.95e-05	0.000453	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—prostate cancer	2.91e-05	0.000448	CcSEcCtD
Spironolactone—Nausea—Docetaxel—prostate cancer	2.89e-05	0.000444	CcSEcCtD
Spironolactone—Diarrhoea—Prednisone—prostate cancer	2.87e-05	0.000441	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.83e-05	0.000435	CcSEcCtD
Spironolactone—Nausea—Capecitabine—prostate cancer	2.79e-05	0.000429	CcSEcCtD
Spironolactone—Progesterone—AR—prostate cancer	2.77e-05	0.01	CrCbGaD
Spironolactone—Drospirenone—PTGS2—prostate cancer	2.77e-05	0.01	CrCbGaD
Spironolactone—Dizziness—Prednisone—prostate cancer	2.77e-05	0.000426	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—prostate cancer	2.7e-05	0.000415	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—prostate cancer	2.7e-05	0.000414	CcSEcCtD
Spironolactone—Vomiting—Prednisone—prostate cancer	2.66e-05	0.000409	CcSEcCtD
Spironolactone—Rash—Prednisone—prostate cancer	2.64e-05	0.000406	CcSEcCtD
Spironolactone—Dermatitis—Prednisone—prostate cancer	2.64e-05	0.000406	CcSEcCtD
Spironolactone—Headache—Prednisone—prostate cancer	2.62e-05	0.000403	CcSEcCtD
Spironolactone—Testosterone—AR—prostate cancer	2.62e-05	0.00948	CrCbGaD
Spironolactone—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.62e-05	0.000402	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—prostate cancer	2.6e-05	0.0004	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—prostate cancer	2.59e-05	0.000398	CcSEcCtD
Spironolactone—Progesterone—CYP3A5—prostate cancer	2.52e-05	0.00911	CrCbGaD
Spironolactone—Feeling abnormal—Doxorubicin—prostate cancer	2.5e-05	0.000384	CcSEcCtD
Spironolactone—Nausea—Prednisone—prostate cancer	2.49e-05	0.000383	CcSEcCtD
Spironolactone—Progesterone—CYP2A6—prostate cancer	2.44e-05	0.00882	CrCbGaD
Spironolactone—Hypersensitivity—Epirubicin—prostate cancer	2.41e-05	0.000371	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—prostate cancer	2.41e-05	0.00037	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—prostate cancer	2.4e-05	0.000368	CcSEcCtD
Spironolactone—Testosterone—CYP3A5—prostate cancer	2.38e-05	0.00861	CrCbGaD
Spironolactone—Pruritus—Epirubicin—prostate cancer	2.32e-05	0.000356	CcSEcCtD
Spironolactone—Hydrocortisone—NR3C1—prostate cancer	2.31e-05	0.00835	CrCbGaD
Spironolactone—Diarrhoea—Epirubicin—prostate cancer	2.24e-05	0.000345	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—prostate cancer	2.23e-05	0.000343	CcSEcCtD
Spironolactone—Testosterone—CYP19A1—prostate cancer	2.2e-05	0.00794	CrCbGaD
Spironolactone—Dizziness—Epirubicin—prostate cancer	2.17e-05	0.000333	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—prostate cancer	2.15e-05	0.00033	CcSEcCtD
Spironolactone—Progesterone—ESR1—prostate cancer	2.14e-05	0.00773	CrCbGaD
Spironolactone—Vomiting—Epirubicin—prostate cancer	2.08e-05	0.00032	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—prostate cancer	2.07e-05	0.000319	CcSEcCtD
Spironolactone—Rash—Epirubicin—prostate cancer	2.07e-05	0.000318	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—prostate cancer	2.06e-05	0.000317	CcSEcCtD
Spironolactone—Headache—Epirubicin—prostate cancer	2.05e-05	0.000316	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—prostate cancer	2.01e-05	0.000308	CcSEcCtD
Spironolactone—Nausea—Epirubicin—prostate cancer	1.95e-05	0.000299	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—prostate cancer	1.93e-05	0.000296	CcSEcCtD
Spironolactone—Rash—Doxorubicin—prostate cancer	1.91e-05	0.000294	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—prostate cancer	1.91e-05	0.000294	CcSEcCtD
Spironolactone—Headache—Doxorubicin—prostate cancer	1.9e-05	0.000292	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	1.89e-05	0.00683	CrCbGaD
Spironolactone—Progesterone—NR3C1—prostate cancer	1.88e-05	0.0068	CrCbGaD
Spironolactone—Nausea—Doxorubicin—prostate cancer	1.8e-05	0.000277	CcSEcCtD
Spironolactone—Methyltestosterone—CYP3A4—prostate cancer	1.78e-05	0.00643	CrCbGaD
Spironolactone—Progesterone—CYP2C19—prostate cancer	1.72e-05	0.0062	CrCbGaD
Spironolactone—Progesterone—CYP1A1—prostate cancer	1.71e-05	0.00618	CrCbGaD
Spironolactone—Testosterone—CYP2C19—prostate cancer	1.62e-05	0.00586	CrCbGaD
Spironolactone—Testosterone—CYP1A1—prostate cancer	1.62e-05	0.00584	CrCbGaD
Spironolactone—Hydrocortisone—CYP3A4—prostate cancer	1.34e-05	0.00484	CrCbGaD
Spironolactone—Progesterone—CYP3A4—prostate cancer	1.09e-05	0.00394	CrCbGaD
Spironolactone—Testosterone—CYP3A4—prostate cancer	1.03e-05	0.00373	CrCbGaD
Spironolactone—ABCB1—Metabolism—LDHB—prostate cancer	2.56e-06	3.71e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ITPR1—prostate cancer	2.55e-06	3.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TBXAS1—prostate cancer	2.54e-06	3.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA4—prostate cancer	2.54e-06	3.69e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SIRT1—prostate cancer	2.54e-06	3.69e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—prostate cancer	2.52e-06	3.66e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB3—prostate cancer	2.52e-06	3.66e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR2—prostate cancer	2.52e-06	3.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP3A5—prostate cancer	2.51e-06	3.64e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—VDR—prostate cancer	2.5e-06	3.63e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—prostate cancer	2.5e-06	3.63e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.5e-06	3.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	2.5e-06	3.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.49e-06	3.61e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—prostate cancer	2.48e-06	3.6e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA2—prostate cancer	2.48e-06	3.6e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—prostate cancer	2.47e-06	3.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.47e-06	3.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SULT1A1—prostate cancer	2.45e-06	3.55e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCG5—prostate cancer	2.45e-06	3.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	2.43e-06	3.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UCP3—prostate cancer	2.42e-06	3.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA3—prostate cancer	2.42e-06	3.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PDHA1—prostate cancer	2.42e-06	3.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TCN2—prostate cancer	2.42e-06	3.52e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—prostate cancer	2.42e-06	3.5e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—prostate cancer	2.4e-06	3.49e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA1—prostate cancer	2.39e-06	3.47e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—prostate cancer	2.38e-06	3.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAT2—prostate cancer	2.37e-06	3.43e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTO1—prostate cancer	2.37e-06	3.43e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD3B2—prostate cancer	2.37e-06	3.43e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—prostate cancer	2.34e-06	3.39e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LPL—prostate cancer	2.33e-06	3.38e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC22A3—prostate cancer	2.31e-06	3.35e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD3B1—prostate cancer	2.31e-06	3.35e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—prostate cancer	2.31e-06	3.35e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ERCC2—prostate cancer	2.29e-06	3.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.27e-06	3.3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLCB2—prostate cancer	2.27e-06	3.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2C18—prostate cancer	2.27e-06	3.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LRP2—prostate cancer	2.27e-06	3.29e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—prostate cancer	2.25e-06	3.27e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—prostate cancer	2.25e-06	3.27e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.24e-06	3.24e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ERCC2—prostate cancer	2.23e-06	3.24e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—prostate cancer	2.23e-06	3.24e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.23e-06	3.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—P4HB—prostate cancer	2.22e-06	3.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA4—prostate cancer	2.22e-06	3.21e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TBXAS1—prostate cancer	2.22e-06	3.21e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CREBBP—prostate cancer	2.21e-06	3.21e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—prostate cancer	2.21e-06	3.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.19e-06	3.17e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC22A1—prostate cancer	2.16e-06	3.14e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—prostate cancer	2.16e-06	3.14e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA2—prostate cancer	2.16e-06	3.13e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—prostate cancer	2.16e-06	3.13e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—prostate cancer	2.15e-06	3.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.14e-06	3.1e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—prostate cancer	2.14e-06	3.1e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SULT1A1—prostate cancer	2.13e-06	3.09e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG5—prostate cancer	2.13e-06	3.09e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARA—prostate cancer	2.11e-06	3.06e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SULT2A1—prostate cancer	2.11e-06	3.06e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BAD—prostate cancer	2.1e-06	3.05e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—prostate cancer	2.1e-06	3.05e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA1—prostate cancer	2.08e-06	3.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MED12—prostate cancer	2.07e-06	3.01e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—prostate cancer	2.07e-06	3.01e-05	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	2.07e-06	3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.07e-06	3e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—prostate cancer	2.06e-06	2.99e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARA—prostate cancer	2.06e-06	2.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD3B2—prostate cancer	2.06e-06	2.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTO1—prostate cancer	2.06e-06	2.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAT2—prostate cancer	2.06e-06	2.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNG5—prostate cancer	2.06e-06	2.98e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—prostate cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—prostate cancer	2.03e-06	2.95e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGF—prostate cancer	2.01e-06	2.92e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS1—prostate cancer	2.01e-06	2.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA3—prostate cancer	1.98e-06	2.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LRP2—prostate cancer	1.98e-06	2.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLCB2—prostate cancer	1.98e-06	2.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2C18—prostate cancer	1.98e-06	2.87e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—prostate cancer	1.96e-06	2.84e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GSK3B—prostate cancer	1.95e-06	2.83e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.95e-06	2.83e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—prostate cancer	1.94e-06	2.81e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—P4HB—prostate cancer	1.94e-06	2.81e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INS—prostate cancer	1.93e-06	2.79e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—prostate cancer	1.91e-06	2.78e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.9e-06	2.75e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HPGDS—prostate cancer	1.89e-06	2.74e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREBBP—prostate cancer	1.89e-06	2.74e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC22A1—prostate cancer	1.88e-06	2.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.88e-06	2.73e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2C19—prostate cancer	1.88e-06	2.73e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—prostate cancer	1.86e-06	2.7e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—prostate cancer	1.86e-06	2.7e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.85e-06	2.69e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SULT2A1—prostate cancer	1.84e-06	2.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.84e-06	2.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—prostate cancer	1.83e-06	2.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACHE—prostate cancer	1.83e-06	2.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2A6—prostate cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MED12—prostate cancer	1.81e-06	2.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.81e-06	2.62e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAP2K1—prostate cancer	1.8e-06	2.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNG5—prostate cancer	1.79e-06	2.6e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—prostate cancer	1.79e-06	2.59e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—prostate cancer	1.78e-06	2.58e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—prostate cancer	1.77e-06	2.57e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—prostate cancer	1.77e-06	2.56e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C3—prostate cancer	1.76e-06	2.56e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PRKACB—prostate cancer	1.75e-06	2.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP17A1—prostate cancer	1.74e-06	2.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA3—prostate cancer	1.73e-06	2.5e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—prostate cancer	1.72e-06	2.5e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGF2—prostate cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—prostate cancer	1.69e-06	2.45e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CREBBP—prostate cancer	1.68e-06	2.43e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INS—prostate cancer	1.67e-06	2.42e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA2—prostate cancer	1.65e-06	2.4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HPGDS—prostate cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JAK2—prostate cancer	1.64e-06	2.38e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2C19—prostate cancer	1.64e-06	2.37e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CREBBP—prostate cancer	1.64e-06	2.37e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—prostate cancer	1.6e-06	2.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACHE—prostate cancer	1.6e-06	2.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—prostate cancer	1.6e-06	2.32e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—prostate cancer	1.58e-06	2.29e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2A6—prostate cancer	1.58e-06	2.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A5—prostate cancer	1.58e-06	2.29e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—prostate cancer	1.57e-06	2.28e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—prostate cancer	1.56e-06	2.26e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—prostate cancer	1.55e-06	2.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.55e-06	2.25e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2E1—prostate cancer	1.54e-06	2.24e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C3—prostate cancer	1.54e-06	2.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PRKACB—prostate cancer	1.53e-06	2.22e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—prostate cancer	1.53e-06	2.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NQO1—prostate cancer	1.52e-06	2.21e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP17A1—prostate cancer	1.51e-06	2.19e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TH—prostate cancer	1.5e-06	2.18e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—prostate cancer	1.5e-06	2.17e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.5e-06	2.17e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.49e-06	2.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP3A4—prostate cancer	1.49e-06	2.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.48e-06	2.14e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—prostate cancer	1.47e-06	2.13e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—prostate cancer	1.46e-06	2.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1B1—prostate cancer	1.46e-06	2.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA2—prostate cancer	1.44e-06	2.09e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—prostate cancer	1.43e-06	2.08e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—prostate cancer	1.43e-06	2.08e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GGT1—prostate cancer	1.42e-06	2.05e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—prostate cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA1—prostate cancer	1.39e-06	2.02e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—prostate cancer	1.38e-06	2.01e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A5—prostate cancer	1.37e-06	1.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—prostate cancer	1.37e-06	1.99e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—prostate cancer	1.36e-06	1.97e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—prostate cancer	1.35e-06	1.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—prostate cancer	1.35e-06	1.95e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2E1—prostate cancer	1.34e-06	1.95e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—prostate cancer	1.34e-06	1.94e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NQO1—prostate cancer	1.33e-06	1.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RXRA—prostate cancer	1.33e-06	1.92e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—prostate cancer	1.31e-06	1.91e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—prostate cancer	1.31e-06	1.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TH—prostate cancer	1.31e-06	1.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP3A4—prostate cancer	1.29e-06	1.88e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.29e-06	1.87e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—prostate cancer	1.28e-06	1.86e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—COMT—prostate cancer	1.28e-06	1.85e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1B1—prostate cancer	1.27e-06	1.85e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—prostate cancer	1.27e-06	1.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ITPR1—prostate cancer	1.25e-06	1.81e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—prostate cancer	1.25e-06	1.81e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—prostate cancer	1.25e-06	1.81e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GGT1—prostate cancer	1.23e-06	1.79e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.23e-06	1.78e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—prostate cancer	1.22e-06	1.77e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA1—prostate cancer	1.21e-06	1.76e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—prostate cancer	1.2e-06	1.75e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—prostate cancer	1.2e-06	1.74e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—prostate cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—prostate cancer	1.18e-06	1.71e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—prostate cancer	1.17e-06	1.7e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—prostate cancer	1.17e-06	1.69e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RXRA—prostate cancer	1.16e-06	1.68e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPL—prostate cancer	1.15e-06	1.66e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—prostate cancer	1.12e-06	1.62e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—prostate cancer	1.12e-06	1.62e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—prostate cancer	1.11e-06	1.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—COMT—prostate cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—prostate cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ERCC2—prostate cancer	1.1e-06	1.59e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—prostate cancer	1.1e-06	1.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ITPR1—prostate cancer	1.09e-06	1.58e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—prostate cancer	1.07e-06	1.56e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—prostate cancer	1.03e-06	1.5e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—prostate cancer	1.03e-06	1.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—prostate cancer	1.03e-06	1.49e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—prostate cancer	1.02e-06	1.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARA—prostate cancer	1.01e-06	1.47e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPL—prostate cancer	9.99e-07	1.45e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—prostate cancer	9.95e-07	1.44e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—prostate cancer	9.65e-07	1.4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ERCC2—prostate cancer	9.57e-07	1.39e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—prostate cancer	9.52e-07	1.38e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—prostate cancer	9.5e-07	1.38e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—prostate cancer	9.19e-07	1.33e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—prostate cancer	9.1e-07	1.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.1e-07	1.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—prostate cancer	8.99e-07	1.3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARA—prostate cancer	8.82e-07	1.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—prostate cancer	8.67e-07	1.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—prostate cancer	8.42e-07	1.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—prostate cancer	8.3e-07	1.2e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—prostate cancer	8.24e-07	1.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INS—prostate cancer	8.21e-07	1.19e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CREBBP—prostate cancer	8.04e-07	1.17e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—prostate cancer	7.76e-07	1.13e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—prostate cancer	7.62e-07	1.11e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—prostate cancer	7.56e-07	1.1e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—prostate cancer	7.2e-07	1.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INS—prostate cancer	7.15e-07	1.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CREBBP—prostate cancer	7.01e-07	1.02e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—prostate cancer	6.9e-07	1e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—prostate cancer	6.74e-07	9.77e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—prostate cancer	6.65e-07	9.64e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—prostate cancer	6.64e-07	9.64e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—prostate cancer	6.59e-07	9.55e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—prostate cancer	6.27e-07	9.1e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—prostate cancer	5.79e-07	8.4e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—prostate cancer	5.74e-07	8.33e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—prostate cancer	5.74e-07	8.32e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—prostate cancer	5.48e-07	7.94e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—prostate cancer	5e-07	7.26e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—prostate cancer	4.77e-07	6.92e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.05e-07	5.88e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—prostate cancer	3.53e-07	5.12e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—prostate cancer	3.31e-07	4.8e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—prostate cancer	2.88e-07	4.18e-06	CbGpPWpGaD
